A comprehensive view of Cysts / Lesions / Tumors. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
US Patent Issued to Bristol-Myers Squibb on April 30 for "Tetrahydropyran-based thiodisaccharide mimics as Galectin-3 inhibitors" (American, Indian Inventors)
Published:
May 01, 2024
by U.S. Fed News
|
'Anti-Ror1 Macrocyclic Peptides And Compositions' in Patent Application Approval Process (USPTO 20240116988)
Published:
May 01, 2024
by Stem Cell Daily
|
Patent Issued for Bispecific antibodies against CD3EPSILON and ROR1 (USPTO 11952421)
Published:
April 30, 2024
by Cancer Daily
|
FDA approves Novartis' Lutathera for treatment of certain pediatric gastroenteropancreatic neuroendocrine tumors; Lutathera is the first therapy specifically approved for such pediatric patients
Published:
April 29, 2024
by CE Noticias Financieras (Latin America)
|
Patent Issued for Compositions and methods for inhibiting transmembrane serine protease 6 (TMPRSS6) expression (USPTO 11952574)
Published:
April 26, 2024
by Disease Prevention Daily
|
Ask us about our Health Care Sector market view